2026 NPPES data Urology Physician NPI 1760485098 M.D.
Verify on CMS →

TERENCE FAVAZZA, M.D.

Urology Physician in LIVE OAK, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 732 beneficiaries · Urology Physician avg: 1K
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$1.2K
26 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: TERENCE FAVAZZA, M.D. is a Urology Physician ([object Object]) practicing in LIVE OAK, Texas with a Medicare Part D prescribing footprint of 3K claims across 732 beneficiaries — 17% brand-name prescribing . Their CMS MIPS Final Score of 75/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $1.2K across 26 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: TERENCE FAVAZZA, M.D. reported a CMS MIPS final score of 75 out of 100, below the 83.1 national average, and filed 2,533 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

TERENCE FAVAZZA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

TERENCE FAVAZZA, M.D. at a glance

Below national average

NPI registry status

Active

Issued 05/31/2005

NPI 1760485098

Primary specialty

Urology Physician

Mid-sized

13,350 US NPIs in this specialty

Medicare Part D claims

2,533 98% vs specialty avg

2023 prescription claims

Specialty avg: 1,280

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Texas

How Urology Physician compares to other specialties among Texas providers

Texas providers

Urology Physician share within Texas

1. Urology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Urology Physician share within Texas

Medicare quality performance — MIPS

TERENCE FAVAZZA, M.D.'s 2023 MIPS final score plotted against the Urology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Urology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Urology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TERENCE FAVAZZA, M.D. is a Urology Physician provider practicing in LIVE OAK, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1760485098. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

TERENCE FAVAZZA, M.D. appears in the CMS NPPES registry as a Urology Physician provider holding M.D. credentials at 12709 TOEPPERWEIN RD STE 206, LIVE OAK, TX, 78233, with a listed phone of (210) 564-8000. NPI 1760485098 was issued on 05/31/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FAVAZZA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,533 prescription claims written by this provider, covering 732 Medicare beneficiaries and totaling roughly $615K in drug spend, split 17% brand-name and 83% generic by claim count, with an opioid prescribing rate of 3.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Urology Physician is a mid-sized specialty nationwide, with 13,350 enrolled providers across 54 states and an average of 1,280 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

12709 TOEPPERWEIN RD STE 206
LIVE OAK, TX 78233

Provider Details

NPI 1760485098
Specialty Urology Physician
Credentials M.D.
Gender Male
NPI Issued 05/31/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Group practice

Hospital and facility affiliations

Facilities where TERENCE FAVAZZA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UROLOGY PARTNERS OF NORTH TEXAS, PLLC
ARLINGTON, TX
UROLOGY SAN ANTONIO P A
LIVE OAK, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TERENCE FAVAZZA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$1.2K

Largest payer

Teleflex LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to TERENCE FAVAZZA, M.D.. To verify TERENCE FAVAZZA, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

TERENCE FAVAZZA, M.D. — brand share 17.0%
Specialty average (est.)

17% brand-name claims vs 83% generic, on 2,533 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,533
Total Claims
$615K
Total Drug Cost
732
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,527
Total Day Supply
158,477
Brand vs Generic
17% brand / 83% generic
Brand Drug Cost
$532K
Generic Drug Cost
$83K
Opioid Claims
85 (3.4% rate)
Antibiotic Claims
346

Patient Demographics

Average Patient Age
73.6 years
Avg HCC Risk Score
1.75
Gender Split
33% female / 67% male
Age Distribution
<65: 73, 65-74: 311, 75-84: 271, 85+: 77

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Tamsulosin Hcl
429
Oxybutynin Chloride Er
Oxybutynin Chloride
297
Myrbetriq
Mirabegron
256
Solifenacin Succinate
234
Finasteride
233
Alfuzosin Hcl Er
Alfuzosin Hcl
104
Nitrofurantoin
Nitrofurantoin Macrocrystal
103
Orgovyx
Relugolix
73
Testosterone Cypionate
72
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
65

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urology Physician Overview

How TERENCE FAVAZZA, M.D. fits within the Urology Physician landscape nationally.

13,350
Urology Physician Providers in US
54
States with Urology Physician
1,280
Avg Claims per Provider

TERENCE FAVAZZA, M.D.'s 2,533 claims are above the specialty average of 1,280.

Nearby Urology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as FAVAZZA.

Compare Urology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is TERENCE FAVAZZA, M.D.'s specialty?
TERENCE FAVAZZA, M.D. specializes in Urology Physician and practices in LIVE OAK, Texas. Credentials: M.D..
How much does TERENCE FAVAZZA, M.D. prescribe under Medicare Part D?
In 2023, TERENCE FAVAZZA, M.D. wrote 2,533 Medicare Part D claims totaling $615K in drug costs for 732 beneficiaries.
What is TERENCE FAVAZZA, M.D.'s Medicare quality score?
TERENCE FAVAZZA, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is TERENCE FAVAZZA, M.D. located?
TERENCE FAVAZZA, M.D. is located at 12709 TOEPPERWEIN RD STE 206, LIVE OAK, TX, 78233. Phone: (210) 564-8000.
What is TERENCE FAVAZZA, M.D.'s NPI number?
TERENCE FAVAZZA, M.D.'s National Provider Identifier (NPI) is 1760485098, issued on 05/31/2005.
Does TERENCE FAVAZZA, M.D. prescribe more brand-name or generic drugs?
TERENCE FAVAZZA, M.D.'s prescribing is 17% brand-name and 83% generic drugs by claim count, with $532K in brand drug costs.
Does TERENCE FAVAZZA, M.D. prescribe opioids?
Yes, TERENCE FAVAZZA, M.D. had 85 opioid claims in 2023 with an opioid prescribing rate of 3.4%.
How many Urology Physician providers are there in the US?
There are 13,350 Urology Physician providers across 54 states in the US. The average Urology Physician provider writes 1,280 Medicare Part D claims per year.
What drugs does TERENCE FAVAZZA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, TERENCE FAVAZZA, M.D.'s most frequently prescribed drugs include Tamsulosin Hcl, Oxybutynin Chloride Er, Myrbetriq. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TERENCE FAVAZZA, M.D. accept Medicare?
TERENCE FAVAZZA, M.D. appears in CMS Medicare data with 2,533 Part D claims and 732 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TERENCE FAVAZZA, M.D.'s credentials?
TERENCE FAVAZZA, M.D.'s NPI is 1760485098 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology